Skip to main content

Advertisement

SpringerLink
Log in

Association of vitamin D receptor gene polymorphism with the occurrence of low bone density, osteopenia, and osteoporosis in patients with type 2 diabetes

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Purpose

This study aims to analyze the association between VDR gene polymorphism and the occurrence of “low bone density (LBD)/osteopenia/osteoporosis” or LBDOO in type 2 diabetes (T2D) patients among a clustered population in northwest of Iran. The studied VDR gene polymorphism included ApaI (rs7975232), BsmI (rs1544410), FokI (rs2228570), EcoRV (rs4516035) and, TaqI (rs731236).

Methods

In this population-based cross-sectional study, patients with T2D were identified within a group of 1266 participants based on self-report of diabetes, history of diabetes medication, and recorded laboratory data. Separately for each polymorphism and gender, crude and adjusted (age, BMI) odds ratios (ORs) were calculated for participants with T2D through logistic regression analysis.

Results

The prevalence of T2D was 16.41% in people residing in the city of Sanandaj in 2011. Of the participants with T2D, 13.92% and 81.29% had osteoporosis and vitamin D deficiency, respectively. In women, the tt genotype of the TaqI gene significantly decreased the risk of LBDOO versus the Tt genotype, after adjusting for BMI and age (adjusted OR:0.18, CI95%: 0.03–0.97). Conversely, the EE genotype of the EcoRV gene enhanced the risk of LBDOO versus the Ee genotype (adjusted OR:7.64, CI95%: 2.03–28.72).

Conclusion

The polymorphism of both TaqI and EcoRV genes was associated with the risk of LBDOO in women with T2D. This is the first time a study has highlighted this effect for the polymorphism of the EcoRV gene; we believe that this study would serve as a basis for future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–33. https://doi.org/10.1007/s00198-006-0172-4.

    Article  CAS  PubMed  Google Scholar 

  2. Nair R, Maseeh A. Vitamin D: the “sunshine” vitamin. J Pharmacol Pharmacother. 2012;3(2):118.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571–6.

    CAS  PubMed  Google Scholar 

  4. Mohammadi Z, Keshtkar A, Fayyazbakhsh F, et al. Prevalence of osteoporosis and vitamin D receptor gene polymorphisms (FokI) in an Iranian general population based study (Kurdistan) (IMOS). Med J Islam Repub Iran. 2015;29:238.

    PubMed  PubMed Central  Google Scholar 

  5. Leidig-Bruckner G, Grobholz S, Bruckner T, et al. Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr Disord. 2014;14(1):33. https://doi.org/10.1186/1472-6823-14-33.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gutzwiller J-P, Richterich J-P, Stanga Z, et al. Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland. BMC Geriatr. 2018;18(1):115. https://doi.org/10.1186/s12877-018-0809-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bohinc B, Snyder JE. The effects of race, ethnicity, and underlying medical diseases on osteoporosis are still unguided territory for internists. Ann Intern Med. 2008;149(7):514–5. https://doi.org/10.7326/0003-4819-149-7-200810070-00019 (author reply 515-516).

    Article  PubMed  Google Scholar 

  8. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363(24):2339–50. https://doi.org/10.1056/NEJMra0906948.

    Article  CAS  PubMed  Google Scholar 

  9. Raje M, Botre C, Ashma R. Genetic epidemiology of osteoporosis across four microsatellite markers near the VDR gene. Int J Mol Epidemiol Genet. 2013;4(2):101–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Gnanaprakash V, Bodhini D, Kanthimathi S, et al. Association of Vitamin D receptor (TaqI, BsmI, and FokI) polymorphisms with prediabetes and Type 2 diabetes in Asian Indians. J Diabetol. 2019;10(1):29.

    Article  Google Scholar 

  11. Peacock M. Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res. 1995;10(9):1294–7. https://doi.org/10.1002/jbmr.5650100904.

    Article  CAS  PubMed  Google Scholar 

  12. Ma X, Jing Y, Qin W, et al. Vitamin D receptor gene polymorphism and bone mineral density in patients with type 2 diabetes mellitus. Chin Med J. 2001;114(11):1213–5.

    CAS  PubMed  Google Scholar 

  13. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367(6460):284–7. https://doi.org/10.1038/367284a0.

    Article  CAS  PubMed  Google Scholar 

  14. Morrison NA, Yeoman R, Kelly PJ, et al. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA. 1992;89(15):6665–9. https://doi.org/10.1073/pnas.89.15.6665.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang L, Yin X, Wang J, et al. Associations between VDR gene polymorphisms and osteoporosis risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis. Sci Rep. 2018;8(1):981. https://doi.org/10.1038/s41598-017-18670-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Al-Daghri NM, Al-Attas O, Alokail MS, et al. Vitamin D receptor gene polymorphisms and HLA DRB1*04 cosegregation in Saudi type 2 diabetes patients. J Immunol. 2012;188(3):1325–32. https://doi.org/10.4049/jimmunol.1101954.

    Article  CAS  PubMed  Google Scholar 

  17. Chakhtoura M, Azar ST. The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. Int J Endocrinol. 2013;2013: 148673. https://doi.org/10.1155/2013/148673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bachali S, Dasu K, Ramalingam K, et al. Vitamin d deficiency and insulin resistance in normal and type 2 diabetes subjects. Indian J Clin Biochem. 2013;28(1):74–8. https://doi.org/10.1007/s12291-012-0239-2.

    Article  CAS  PubMed  Google Scholar 

  19. Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8. https://doi.org/10.2337/dc12-0962.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65(9):1005–15. https://doi.org/10.1038/ejcn.2011.118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mitri J, Dawson-Hughes B, Hu FB, et al. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94(2):486–94. https://doi.org/10.3945/ajcn.111.011684.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Joergensen C, Hovind P, Schmedes A, et al. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care. 2011;34(5):1081–5. https://doi.org/10.2337/dc10-2459.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Joergensen C, Gall MA, Schmedes A, et al. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care. 2010;33(10):2238–43. https://doi.org/10.2337/dc10-0582.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ortlepp JR, Lauscher J, Hoffmann R, et al. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med. 2001;18(10):842–5. https://doi.org/10.1046/j.1464-5491.2001.00585.x.

    Article  CAS  PubMed  Google Scholar 

  25. Neyestani TR, Djazayery A, Shab-Bidar S, et al. Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care. 2013;36(3):550–6. https://doi.org/10.2337/dc12-0919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Malik R, Farooq R, Mehta P, et al. Association of vitamin D receptor gene polymorphism in adults with type 2 diabetes in the Kashmir Valley. Can J Diabetes. 2017;42:251–6. https://doi.org/10.1016/j.jcjd.2017.06.003.

    Article  PubMed  Google Scholar 

  27. Zhong X, Du Y, Lei Y, et al. Effects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patients. Gene. 2015;566(2):212–6. https://doi.org/10.1016/j.gene.2015.04.045.

    Article  CAS  PubMed  Google Scholar 

  28. Shab-Bidar S, Neyestani TR, Djazayery A. Vitamin D receptor gene polymorphisms, metabolic syndrome, and type 2 diabetes in Iranian subjects: no association with observed SNPs. Int J Vitam Nutr Res. 2016;86(1–2):71–80. https://doi.org/10.1024/0300-9831/a000270.

    Article  CAS  PubMed  Google Scholar 

  29. Malecki MT, Frey J, Moczulski D, et al. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes. 2003;111(8):505–9. https://doi.org/10.1055/s-2003-44711.

    Article  CAS  PubMed  Google Scholar 

  30. Keshtkar A, Khashayar P, Mohammadi Z, et al. A suggested prototype for assessing bone health. Arch Iran Med. 2015;18(7):411–5.

    PubMed  Google Scholar 

  31. Demmer RT, Zuk AM, Rosenbaum M, et al. Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999–2010. Am J Epidemiol. 2013;178(7):1106–13. https://doi.org/10.1093/aje/kwt088.

    Article  PubMed  PubMed Central  Google Scholar 

  32. DeShields SC, Cunningham TD. Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus. J Endocrinol Invest. 2018;41(9):1051–60. https://doi.org/10.1007/s40618-018-0828-x.

    Article  CAS  PubMed  Google Scholar 

  33. Comino EJ, Tran DT, Haas M, et al. Validating self-report of diabetes use by participants in the 45 and up study: a record linkage study. BMC Health Serv Res. 2013;13(1):481. https://doi.org/10.1186/1472-6963-13-481.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bonjour JP, Ammann P, Rizzoli R. Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines. Osteoporos Int. 1999;9(5):379–93. https://doi.org/10.1007/s001980050161.

    Article  CAS  PubMed  Google Scholar 

  35. Dimai HP. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone. 2017;104:39–43. https://doi.org/10.1016/j.bone.2016.12.016.

    Article  PubMed  Google Scholar 

  36. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. https://doi.org/10.1210/jc.2011-0385.

    Article  CAS  PubMed  Google Scholar 

  37. Lang TA, Altman DG. Basic statistical reporting for articles published in biomedical journals: the “statistical analyses and methods in the published literature” or the SAMPL guidelines. Int J Nurs Stud. 2015;52(1):5–9. https://doi.org/10.1016/j.ijnurstu.2014.09.006.

    Article  PubMed  Google Scholar 

  38. World Health Organization. Global report on diabetes. World Health Organization; 2016. https://apps.who.int/iris/handle/10665/204871. Accessed 15 Feb 2021.

  39. Larejani B, Zahedi F. Epidemiology of diabetes mellitus in iran. Iran J Diabetes Lipid Disord. 2001;1(1):1–8.

    Google Scholar 

  40. Doosti Irani A, Poorolajal J, Khalilian A, et al. Prevalence of osteoporosis in Iran: a meta-analysis. J Res Med Sci. 2013;18(9):759–66.

    Google Scholar 

  41. Rahimi MA, Izadi N, Niromand E, et al. Comparison of serum level of 25-hydroxy vitamin d in diabetic patients and healthy subjects. Med J Mashhad Univ Med Sci. 2016;59(2):97–105.

    Google Scholar 

  42. Rahimzadeh F, Pedram M, Kruk MC. An examination of the trends in sunshine hours over Iran. Meteorol Appl. 2014;21(2):309–15.

    Article  Google Scholar 

  43. Jia F, Sun RF, Li QH, et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genet Test Mol Biomark. 2013;17(1):30–4. https://doi.org/10.1089/gtmb.2012.0267.

    Article  CAS  Google Scholar 

  44. Salamone LM, Ferrell R, Black DM, et al. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int. 1996;6(1):63–8. https://doi.org/10.1007/BF01626540.

    Article  CAS  PubMed  Google Scholar 

  45. Křenek P, Benešová Y, Bienertová-Vašků J, et al. The impact of five VDR polymorphisms on multiple sclerosis risk and progression: a case-control and genotype-phenotype study. J Mol Neurosci. 2018;64(4):559–66.

    Article  Google Scholar 

  46. Mohammadi Z, Fayyazbakhsh F, Ebrahimi M, et al. Association between vitamin D receptor gene polymorphisms (Fok1 and Bsm1) and osteoporosis: a systematic review. J Diabetes Metab Disord. 2014;13(1):98. https://doi.org/10.1186/s40200-014-0098-x.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Angel B, Lera L, Marquez C, et al. The association of VDR polymorphisms and type 2 diabetes in older people living in community in Santiago de Chile. Nutr Diabetes. 2018;8(1):31. https://doi.org/10.1038/s41387-018-0038-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Candido FG, Bressan J. Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014;15(4):6569–91. https://doi.org/10.3390/ijms15046569.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kurt O, Yilmaz-Aydogan H, Uyar M, et al. Evaluation of ERalpha and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women. Mol Biol Rep. 2012;39(6):6723–30. https://doi.org/10.1007/s11033-012-1496-0.

    Article  CAS  PubMed  Google Scholar 

  50. Wawrzyniak A, Krela-Kazmierczak I, Marcinkowska M, et al. Vitamin D receptor gene foki polymorphism and the efficacy of postmenopausal osteoporosis treatment with denosumab. Osteoporosis Int. 2018;29:S504–S504.

    Google Scholar 

  51. An M, Song XB, Chen XY. Vitamin D receptor BsmI polymorphism may be associated with an decreased osteoporosis risk in South China. Cell Mol Biol. 2017;63(5):50–4. https://doi.org/10.14715/cmb/2017.63.5.10.

    Article  CAS  PubMed  Google Scholar 

  52. Borjas-Fajardo L, Zambrano M, Fernandez E, et al. Analysis of Bsm I polymorphism of the vitamin D receptor (VDR) gene in Venezuelan female patients living in the state of Zulia with osteoporosis. Invest Clin. 2003;44(4):275–82.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors of this article consider it their duty to thank the staff of the Sanandaj health network, the participants, and all the EMRI staff who contributed to conducting the IMOS studies.

Author information

Author notes

  1. Fariba Zarrabi

    Present address: Thrombosis Hemostasis Research Center, Tehran University of Medical Sciences, Tehran, Iran

  2. Patricia Khashayar

    Present address: Center for Microsystem Technology, Imec and Ghent University, Zwijnaarde, Ghent, Belgium

Authors and Affiliations

  1. Diabetes Research Center (DRC), Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Maryam Ghodsi, Farideh Razi & Ensieh Nasli-Esfahani

  2. Department of Health Sciences Education Development, School of Public Health (SPH), Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Abbas Ali Keshtkar

  3. Metabolic Disorders Research Center (MDRC), Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Mahsa Mohammad Amoli

  4. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

    Fariba Zarrabi

  5. Osteoporosis Research Center (ORC), Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Patricia Khashayar

  6. Student Research Committee, Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Alireza Khajavi

  7. Endocrinology and Metabolism Research Center (EMRC), Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Bagher Larijani & Mohamad Reza Mohajeri-Tehrani

Authors
  1. Maryam Ghodsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abbas Ali Keshtkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Farideh Razi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahsa Mohammad Amoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ensieh Nasli-Esfahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fariba Zarrabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Patricia Khashayar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alireza Khajavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mohamad Reza Mohajeri-Tehrani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohamad Reza Mohajeri-Tehrani.

Ethics declarations

Conflict of interest

All authors state that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghodsi, M., Keshtkar, A.A., Razi, F. et al. Association of vitamin D receptor gene polymorphism with the occurrence of low bone density, osteopenia, and osteoporosis in patients with type 2 diabetes. J Diabetes Metab Disord 20, 1375–1383 (2021). https://doi.org/10.1007/s40200-021-00871-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-021-00871-7

Keywords

Search

Navigation